Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.

ID
Name
GEN112
Description
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Trial arms
Trial start
2007-05-01
Estimated PCD
2008-10-01
Trial end
2008-12-01
Status
Terminated
Phase
Early phase I
Treatment
CHOP + CD4
Arms:
1
CHOP
Arms:
2
Size
5
Primary endpoint
Primary Outcome Unavailable
Eligibility criteria
Inclusion Criteria: * study is closed to enrollment Exclusion Criteria: * study is closed to enrollment
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 5, 'type': 'ACTUAL'}}
Updated at
2024-04-09

1 organization

2 products

1 indication

Organization
Emergent Biosolutions
Product
CHOP + CD4
Indication
T-cell Lymphoma
Product
CHOP